Payor-mandated “white bagging” is jeopardizing patient safety and exacerbating supply chain problems for hospitals and health systems, the ASHP and 61 health systems and group purchasing organizations recently told FDA Commissioner Janet Woodcock, MD, in a letter requesting a meeting to discuss the practice.
White bagging typically involves clinician-administered drugs given to nonhospitalized patients—often infusion-based drugs that patients cannot take safely on